-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
Adaptimmune Therapeutics PLC quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2013 to 2023.
- Adaptimmune Therapeutics PLC Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $102K, a 95.7% decline year-over-year.
- Adaptimmune Therapeutics PLC annual Payments to Acquire Property, Plant, and Equipment for 2023 was $4.68M, a 84.1% decline from 2022.
- Adaptimmune Therapeutics PLC annual Payments to Acquire Property, Plant, and Equipment for 2022 was $29.5M, a 244% increase from 2021.
- Adaptimmune Therapeutics PLC annual Payments to Acquire Property, Plant, and Equipment for 2021 was $8.57M, a 266% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)